Anna Katherine Krawisz, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 8 | 2024 | 1272 | 2.030 |
Why?
|
Endarterectomy, Carotid | 2 | 2021 | 555 | 1.030 |
Why?
|
Endovascular Procedures | 3 | 2023 | 2181 | 0.900 |
Why?
|
Carotid Stenosis | 2 | 2021 | 860 | 0.900 |
Why?
|
Femoral Artery | 4 | 2023 | 827 | 0.870 |
Why?
|
Popliteal Artery | 3 | 2021 | 310 | 0.830 |
Why?
|
Coated Materials, Biocompatible | 2 | 2021 | 312 | 0.790 |
Why?
|
Intermittent Claudication | 1 | 2021 | 304 | 0.620 |
Why?
|
Drug-Eluting Stents | 2 | 2021 | 681 | 0.580 |
Why?
|
Paclitaxel | 3 | 2021 | 1732 | 0.570 |
Why?
|
Angioplasty, Balloon | 1 | 2021 | 588 | 0.560 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 877 | 0.490 |
Why?
|
Vascular Patency | 3 | 2024 | 910 | 0.480 |
Why?
|
Cardiovascular Agents | 1 | 2021 | 840 | 0.470 |
Why?
|
Healthcare Disparities | 3 | 2023 | 3357 | 0.350 |
Why?
|
Medicare | 5 | 2024 | 6770 | 0.260 |
Why?
|
Hypertension, Renovascular | 1 | 2024 | 116 | 0.220 |
Why?
|
Atherectomy | 1 | 2023 | 41 | 0.220 |
Why?
|
Stroke | 2 | 2021 | 9756 | 0.200 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2024 | 292 | 0.190 |
Why?
|
Stents | 2 | 2021 | 3179 | 0.160 |
Why?
|
Limb Salvage | 1 | 2022 | 481 | 0.160 |
Why?
|
DiGeorge Syndrome | 1 | 2020 | 185 | 0.160 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2566 | 0.160 |
Why?
|
Treatment Outcome | 8 | 2024 | 64651 | 0.150 |
Why?
|
Exercise Therapy | 1 | 2024 | 928 | 0.140 |
Why?
|
Hypolipidemic Agents | 1 | 2021 | 609 | 0.140 |
Why?
|
Angioplasty | 1 | 2019 | 354 | 0.130 |
Why?
|
Calcium Signaling | 1 | 2020 | 733 | 0.130 |
Why?
|
United States | 8 | 2024 | 72339 | 0.120 |
Why?
|
Renal Dialysis | 1 | 2024 | 1797 | 0.120 |
Why?
|
Risk Factors | 5 | 2024 | 74167 | 0.110 |
Why?
|
Self Tolerance | 1 | 2013 | 123 | 0.100 |
Why?
|
Kidney Failure, Chronic | 1 | 2024 | 2471 | 0.100 |
Why?
|
Risk Assessment | 3 | 2021 | 23990 | 0.090 |
Why?
|
Chromosome Disorders | 1 | 2013 | 499 | 0.090 |
Why?
|
Patient Discharge | 1 | 2024 | 3441 | 0.090 |
Why?
|
Aged | 8 | 2024 | 169235 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3340 | 0.090 |
Why?
|
Humans | 17 | 2024 | 761423 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1852 | 0.080 |
Why?
|
Thymus Gland | 1 | 2013 | 1243 | 0.080 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2008 | 55 | 0.080 |
Why?
|
Neurons | 2 | 2020 | 9462 | 0.080 |
Why?
|
Retrospective Studies | 5 | 2024 | 80582 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2900 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5291 | 0.070 |
Why?
|
Female | 12 | 2024 | 392581 | 0.070 |
Why?
|
Male | 10 | 2024 | 360736 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 1931 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58956 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14599 | 0.060 |
Why?
|
Registries | 1 | 2021 | 8223 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2020 | 5776 | 0.060 |
Why?
|
Synapses | 1 | 2013 | 1769 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2013 | 4370 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15838 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2024 | 187 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21341 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2013 | 3667 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4414 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10718 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11458 | 0.040 |
Why?
|
Tubulin Modulators | 1 | 2019 | 107 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2013 | 1827 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1203 | 0.030 |
Why?
|
Transcription Factors | 2 | 2013 | 12125 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 740 | 0.030 |
Why?
|
GABA Agents | 1 | 2013 | 41 | 0.030 |
Why?
|
Adult | 3 | 2024 | 221148 | 0.030 |
Why?
|
Extremities | 1 | 2019 | 867 | 0.030 |
Why?
|
Receptors, Glutamate | 1 | 2013 | 228 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2013 | 346 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2013 | 819 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 508 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2020 | 11526 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7238 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 965 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1494 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2013 | 1444 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2013 | 1387 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1860 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 220826 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2013 | 1253 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2013 | 1173 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1600 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10548 | 0.020 |
Why?
|
Pluripotent Stem Cells | 1 | 2013 | 799 | 0.020 |
Why?
|
Lymphocyte Depletion | 1 | 2008 | 602 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10498 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2415 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1994 | 0.020 |
Why?
|
Autoimmunity | 1 | 2013 | 1355 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7956 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7874 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26112 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3268 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10203 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9535 | 0.010 |
Why?
|
Mice | 3 | 2013 | 81509 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15605 | 0.010 |
Why?
|
Trans-Activators | 1 | 2008 | 2856 | 0.010 |
Why?
|
Animals | 3 | 2013 | 168441 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11902 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4575 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59207 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2008 | 5794 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14409 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23441 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22163 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18247 | 0.010 |
Why?
|
Child | 1 | 2013 | 80162 | 0.000 |
Why?
|